Related Experiment Videos
Platelet clumping in Ph-negative myeloproliferative syndromes
1Department of Internal Medicine, University Hospital, Umeå, Sweden.
Acta Medica Scandinavica
|January 1, 1987
Summary
Platelet clumping in EDTA anticoagulated blood samples can affect automated platelet counts in patients with myeloproliferative diseases. Minimizing sample delay to analysis can resolve this confounding factor.
Area of Science:
- Hematology
- Clinical Pathology
Background:
- Platelet clumping is an in vitro phenomenon observed in blood samples.
- Automated platelet counts can be affected by platelet aggregates.
Purpose of the Study:
- To investigate the prevalence of platelet clumping in patients with myeloproliferative diseases (MPDs) other than chronic myeloid leukemia.
- To assess the impact of platelet clumping on automated platelet counts in MPD patients.
- To identify strategies to mitigate the confounding effects of platelet clumping.
Main Methods:
- Retrospective analysis of 49 patients with MPDs (excluding CML).
- Utilized H6000 imaging to detect platelet clumping (presence of platelet aggregates).
- Prospective study to evaluate a solution for minimizing sample delay.
Main Results:
- Evidence of platelet clumping was found in 17 out of 49 patients (35%).
- Platelet clumping occurred unpredictably.
- Optimizing hospital routine to minimize delay between sampling and analysis resolved the issue.
Conclusions:
- Platelet clumping is a significant confounding factor in automated platelet counts for MPD patients.
- Minimizing the time between blood sampling and analysis is crucial for accurate platelet counts.
- Standardizing pre-analytical procedures can improve diagnostic reliability.